SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Earnings Guidance for the Full Year Ending March 31, 2020; Provides Dividend Guidance for the Second Quarter of Fiscal Year 2020 and Full Year Ending March 31, 2020
The company provided earnings guidance for the full year ending March 31, 2020. The company expects net sales of JPY 13,550 million, operating income of JPY 1,110 million, net income of JPY 1,110 million and earnings per share of JPY 141.74.
The company provided dividend guidance for the second quarter of fiscal year 2020 and full year ending March 31, 2020. The company expects second quarter end dividend of JPY 12.50 per share compared to JPY 12.50 per share paid a year ago.
The company expects year-end dividend of JPY 12.50 per share for the full year ending March 31, 2020 compared to JPY 12.50 per share paid a year ago.